The illustrious S&P/ASX 200 Index (ASX: XJO) is recognised as the institutional investable benchmark in Australia. It has been designed to measure the performance of the 200 largest index-eligible stocks listed on the ASX by float-adjusted market capitalisation
As readers will be aware, there has been significant weakness in certain areas of the market this year, which has hit share prices hard.
In light of this, you may be surprised to learn that the shares listed below are still part of the ASX 200. Well, at least until the next quarterly rebalance in June.
Here are three shares that are clinging precariously to their ASX 200 status:
Clinuvel Pharmaceuticals Limited (ASX: CUV)
The Clinuvel share price is down 1% to $17.08 on Tuesday afternoon. This means the biopharmaceutical company’s shares have now lost over 40% of their value since the start of the year. This means that with 49.4 million shares outstanding, Clinuvel has seen its market capitalisation fall to $843 million.
PolyNovo Ltd (ASX: PNV)
The PolyNovo share price is edging lower again on Tuesday and is down 1% to $1.04. This latest decline means the medical device company’s shares have lost a third of their value in 2022 and a whopping 64% over the last 12 months. In light of this share price weakness, the company now has a market capitalisation of just $688 million.
Zip Co Ltd (ASX: Z1P)
Finally, the Zip share price has tumbled to a two-year low of $1.32 this afternoon. This means the buy now pay later provider’s shares are down 70% in 2022 and 84% over the last 12 months. Given this severe decline, it will come as no surprise to learn that its market capitalisation has taken a major hit. With approximately 685.3 million shares outstanding, Zip has a market cap of $904 million.
Foolish Takeaway
In just under two months, S&P Dow Jones Indices will announce its next rebalance. Unless there is a major improvement in their respective market capitalisations, the three shares above are potentially going to be candidates for eviction from the index. Stay tuned for that.
The post 3 beaten up shares you might be surprised to learn are still part of the ASX 200 appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Why A2 Milk, G8 Education, Nearmap, and Zip shares are dropping
- Zip shares hit new multi-year low. What’s going on?
- The Zip share price is a buy with 180% upside: broker
- These were the worst 3 ASX All Ordinaries shares to hold during the March quarter
- These are the 10 most shorted ASX shares
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended POLYNOVO FPO and ZIPCOLTD FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/5Nb2vEA
Leave a Reply